Literature DB >> 24605238

Surgical treatment of chylothorax caused by lymphangioleiomyomatosis.

Mingliang Liu1, Bingqun Wu1, Yong Cui1, Dong Chang1, Shuhong Zhang1, Min Gong1.   

Abstract

Lymphangioleiomyomatosis (LAM) is a rare progressive disease caused by infiltration of smooth muscle-like cells in lymph vessels as well as the lung. We report a case of pulmonary LAM in a 22-year-old female with shortness of breath, recurrent pneumothorax and chylous pleural effusions. Multiple ligation of thoracic in lower part of thoracic duct was performed and biopsy of thoracic duct confirmed the diagnosis of LAM. The operation was successful and the patient was discharged. Although the thoracic duct involvement is extensive, multiple ligation in lower part of thoracic duct may be a good choice.

Entities:  

Keywords:  Lymphangioleiomyomatosis (LAM); biopsy; chylothorax; surgery; thoracic duct

Year:  2014        PMID: 24605238      PMCID: PMC3944183          DOI: 10.3978/j.issn.2072-1439.2014.01.15

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  12 in total

Review 1.  Chylothorax complicating thoracic surgery: conservative or early surgical management?

Authors:  Panagiotis Misthos; Meletios A Kanakis; Achilleas G Lioulias
Journal:  Updates Surg       Date:  2012-01-13

2.  Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs.

Authors:  Marsha A Moses; Jay Harper; Judah Folkman
Journal:  N Engl J Med       Date:  2006-06-15       Impact factor: 91.245

Review 3.  Treatment options in patients with chylothorax.

Authors:  Hans H Schild; Christian P Strassburg; Armin Welz; Jörg Kalff
Journal:  Dtsch Arztebl Int       Date:  2013-11-29       Impact factor: 5.594

4.  European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis.

Authors:  S R Johnson; J F Cordier; R Lazor; V Cottin; U Costabel; S Harari; M Reynaud-Gaubert; A Boehler; M Brauner; H Popper; F Bonetti; C Kingswood
Journal:  Eur Respir J       Date:  2010-01       Impact factor: 16.671

5.  [Lymphangioleiomyomatosis: new therapeutic approaches].

Authors:  Alvaro Casanova; Julio Ancochea
Journal:  Arch Bronconeumol       Date:  2011-09-15       Impact factor: 4.872

6.  Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone.

Authors:  Angelo M Taveira-DaSilva; Mario P Stylianou; Carolyn J Hedin; Olanda Hathaway; Joel Moss
Journal:  Chest       Date:  2004-12       Impact factor: 9.410

7.  Chyloperitoneum, chylothorax and lower extremity lymphedema in woman with sporadic lymphangioleiomyomatosis successfully treated with sirolimus: a case report.

Authors:  A Chachaj; K Drozdz; M Chabowski; P Dziegiel; I Grzegorek; A Wojnar; P Jazwiec; A Szuba
Journal:  Lymphology       Date:  2012-06       Impact factor: 1.286

8.  Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis.

Authors:  E C Harknett; W Y C Chang; S Byrnes; J Johnson; R Lazor; M M Cohen; B Gray; S Geiling; H Telford; A E Tattersfield; R B Hubbard; S R Johnson
Journal:  QJM       Date:  2011-07-15

9.  [Seventeen cases of lung transplantations for lymphangioleiomyomatosis].

Authors:  Koko Adachi; Shin Kurosawa; Toshihiro Wagatsuma; Eri Kameyama
Journal:  Masui       Date:  2012-11

10.  Effect of a gonadotrophin-releasing hormone analogue on lung function in lymphangioleiomyomatosis.

Authors:  Sergio Harari; Roberto Cassandro; Iacopo Chiodini; Jacopo Chiodini; Angelo M Taveira-DaSilva; Joel Moss
Journal:  Chest       Date:  2007-12-10       Impact factor: 9.410

View more
  2 in total

Review 1.  Recent advances in the management of lymphangioleiomyomatosis.

Authors:  Kai-Feng Xu; Xinlun Tian; Jay H Ryu
Journal:  F1000Res       Date:  2018-06-18

2.  Boerhaave Syndrome, Pneumothorax, and Chylothorax in a Critically Ill Patient with Tuberous Sclerosis Complex.

Authors:  Mohsin Ijaz; Arsalan Rafiq; Sindhaghatta Venkatram; Gilda Diaz-Fuentes
Journal:  Case Rep Crit Care       Date:  2015-10-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.